SynthesisNeuroradiology2026
Endovascular treatment of symptomatic vasospasm and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage - a systematic review and meta-analysis.
Synthesis in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndovascular rescue therapy, including intra-arterial spasmolysis and balloon angioplasty, is widely used for symptomatic vasospasm and delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH), but its impact on functional recovery is unclear. We systematically reviewed evidence on patient-centered outcomes, including effects by follow-up time, intervention type, and clinical severity.
methodsPubMed, EMBASE, and Web of Science were searched (2000–2024; updated July 2025). Prospective and retrospective studies of adults with aSAH receiving endovascular treatment for symptomatic vasospasm/DCI were included. Data extraction followed a PICO framework, and quality was assessed using the Newcastle–Ottawa Scale. Due to inconsistent reporting of angiographic resolution and DCI-related infarction, quantitative synthesis focused on dichotomized favorable functional outcome. Single-arm proportions were pooled using random-effects generalized linear mixed models with prespecified subgroup analyses.
resultsThirty-nine studies (1,627 patients) were included; 38 contributed to pooled analysis. The proportion of favorable functional outcome was 0.55 (95% CI 0.50–0.61), with substantial heterogeneity (I² ≈ 71%). Subgroup analyses by follow-up duration, intervention modality, and baseline severity showed no significant differences. The two randomized trials reported conflicting results and had limited follow-up. Safety reporting varied but was generally acceptable for pharmacologic spasmolysis; some series suggested higher complication rates with mechanical interventions.
conclusionApproximately half of patients treated with endovascular rescue for symptomatic vasospasm/DCI achieve a favorable functional outcome. However, marked heterogeneity and predominantly observational evidence limit conclusions regarding effectiveness. Standardized, adequately powered randomized trials are needed to clarify the role of endovascular rescue after aSAH.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.